Cargando…

PLA-PEG Nanoparticles Improve the Anti-Inflammatory Effect of Rosiglitazone on Macrophages by Enhancing Drug Uptake Compared to Free Rosiglitazone

Among cardiovascular diseases, atherosclerosis remains the first cause of death in the United States of America and Europe, as it leads to myocardial infarction or stroke. The high prevalence of heart diseases is due to the difficulty in diagnosing atherosclerosis, since it can develop for decades b...

Descripción completa

Detalles Bibliográficos
Autores principales: Giacalone, Giovanna, Tsapis, Nicolas, Mousnier, Ludivine, Chacun, Hélène, Fattal, Elias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213468/
https://www.ncbi.nlm.nih.gov/pubmed/30262751
http://dx.doi.org/10.3390/ma11101845
_version_ 1783367777859403776
author Giacalone, Giovanna
Tsapis, Nicolas
Mousnier, Ludivine
Chacun, Hélène
Fattal, Elias
author_facet Giacalone, Giovanna
Tsapis, Nicolas
Mousnier, Ludivine
Chacun, Hélène
Fattal, Elias
author_sort Giacalone, Giovanna
collection PubMed
description Among cardiovascular diseases, atherosclerosis remains the first cause of death in the United States of America and Europe, as it leads to myocardial infarction or stroke. The high prevalence of heart diseases is due to the difficulty in diagnosing atherosclerosis, since it can develop for decades before symptoms occur, and to the complexity of the treatment since targets are also important components of the host defenses. The antidiabetics thiazolidinediones, among which is rosiglitazone (RSG), have demonstrated anti-atherosclerotic effect in animal models, and are therefore promising candidates for the improvement of atherosclerosis management. Nevertheless, their administration is hindered by the insurgence of severe side effects. To overcome this limitation, rosiglitazone has been encapsulated into polymeric nanoparticles, which permit efficient delivery to its nuclear target, and selective delivery to the site of action, allowing the reduction of unwanted effects. In the present work, we describe nanoparticle formulation using polylactic acid (PLA) coupled to polyethylene glycol (PEG), their characterization, and their behavior on RAW264.7 macrophages, an important target in atherosclerosis treatment. RSG nanocarriers showed no toxicity on cells at all concentrations tested, an anti-inflammatory effect in a dose-dependent manner, up to 5 times more efficient than the free molecule, and an increased RSG uptake which is consistent with the effect shown. These biodegradable nanoparticles represent a valid tool to be further investigated for the treatment of atherosclerosis.
format Online
Article
Text
id pubmed-6213468
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62134682018-11-14 PLA-PEG Nanoparticles Improve the Anti-Inflammatory Effect of Rosiglitazone on Macrophages by Enhancing Drug Uptake Compared to Free Rosiglitazone Giacalone, Giovanna Tsapis, Nicolas Mousnier, Ludivine Chacun, Hélène Fattal, Elias Materials (Basel) Article Among cardiovascular diseases, atherosclerosis remains the first cause of death in the United States of America and Europe, as it leads to myocardial infarction or stroke. The high prevalence of heart diseases is due to the difficulty in diagnosing atherosclerosis, since it can develop for decades before symptoms occur, and to the complexity of the treatment since targets are also important components of the host defenses. The antidiabetics thiazolidinediones, among which is rosiglitazone (RSG), have demonstrated anti-atherosclerotic effect in animal models, and are therefore promising candidates for the improvement of atherosclerosis management. Nevertheless, their administration is hindered by the insurgence of severe side effects. To overcome this limitation, rosiglitazone has been encapsulated into polymeric nanoparticles, which permit efficient delivery to its nuclear target, and selective delivery to the site of action, allowing the reduction of unwanted effects. In the present work, we describe nanoparticle formulation using polylactic acid (PLA) coupled to polyethylene glycol (PEG), their characterization, and their behavior on RAW264.7 macrophages, an important target in atherosclerosis treatment. RSG nanocarriers showed no toxicity on cells at all concentrations tested, an anti-inflammatory effect in a dose-dependent manner, up to 5 times more efficient than the free molecule, and an increased RSG uptake which is consistent with the effect shown. These biodegradable nanoparticles represent a valid tool to be further investigated for the treatment of atherosclerosis. MDPI 2018-09-27 /pmc/articles/PMC6213468/ /pubmed/30262751 http://dx.doi.org/10.3390/ma11101845 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Giacalone, Giovanna
Tsapis, Nicolas
Mousnier, Ludivine
Chacun, Hélène
Fattal, Elias
PLA-PEG Nanoparticles Improve the Anti-Inflammatory Effect of Rosiglitazone on Macrophages by Enhancing Drug Uptake Compared to Free Rosiglitazone
title PLA-PEG Nanoparticles Improve the Anti-Inflammatory Effect of Rosiglitazone on Macrophages by Enhancing Drug Uptake Compared to Free Rosiglitazone
title_full PLA-PEG Nanoparticles Improve the Anti-Inflammatory Effect of Rosiglitazone on Macrophages by Enhancing Drug Uptake Compared to Free Rosiglitazone
title_fullStr PLA-PEG Nanoparticles Improve the Anti-Inflammatory Effect of Rosiglitazone on Macrophages by Enhancing Drug Uptake Compared to Free Rosiglitazone
title_full_unstemmed PLA-PEG Nanoparticles Improve the Anti-Inflammatory Effect of Rosiglitazone on Macrophages by Enhancing Drug Uptake Compared to Free Rosiglitazone
title_short PLA-PEG Nanoparticles Improve the Anti-Inflammatory Effect of Rosiglitazone on Macrophages by Enhancing Drug Uptake Compared to Free Rosiglitazone
title_sort pla-peg nanoparticles improve the anti-inflammatory effect of rosiglitazone on macrophages by enhancing drug uptake compared to free rosiglitazone
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213468/
https://www.ncbi.nlm.nih.gov/pubmed/30262751
http://dx.doi.org/10.3390/ma11101845
work_keys_str_mv AT giacalonegiovanna plapegnanoparticlesimprovetheantiinflammatoryeffectofrosiglitazoneonmacrophagesbyenhancingdruguptakecomparedtofreerosiglitazone
AT tsapisnicolas plapegnanoparticlesimprovetheantiinflammatoryeffectofrosiglitazoneonmacrophagesbyenhancingdruguptakecomparedtofreerosiglitazone
AT mousnierludivine plapegnanoparticlesimprovetheantiinflammatoryeffectofrosiglitazoneonmacrophagesbyenhancingdruguptakecomparedtofreerosiglitazone
AT chacunhelene plapegnanoparticlesimprovetheantiinflammatoryeffectofrosiglitazoneonmacrophagesbyenhancingdruguptakecomparedtofreerosiglitazone
AT fattalelias plapegnanoparticlesimprovetheantiinflammatoryeffectofrosiglitazoneonmacrophagesbyenhancingdruguptakecomparedtofreerosiglitazone